Skip to main content

Table 5 Logistic regression model of the odds ratio of the EACS Guidelines Unlisted regimens in 333 HIV/HBV co-infected patients currently on anti-HBV treatment

From: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Characteristics

EACS GU regimens adjusted OR

 

(95% CI)

P

N. enrolled per center§

  

≥20 patients

0.56 (0.23-1.37)

0.2

Female gender

1.92 (0.71-5.18)

0.2

Immigrant status

  

Foreign birth

1.4 (0.71-2.74)

0.33

Age at diagnosis

  

10 years increase

1.23 (1.02-1.48)

0.03

Years since diagnosis*

 

0.12

2-10

0.68 (0.24-1.9)

<10

1.08 (0.39-3.04)

Alcohol consumption

  

Ever

2.21 (0.84-5.86)

0.11

Disease stage°

  

Cirrhosis/HCC

1.57 (0.75-3.29)

0.23

HBeAg

  

Positivity

0.83 (0.44-1.55)

0.56

HCV co-infection

  

Yes

2.74 (1.39-5.41)

0.004

HDV co-infection

  

Yes

0.41 (0.18-0.93)

0.03

Previous treatment

  

Yes

0.4 (0.19-0.83)

0.01

  1. Reference: § = ≤20 patients enrolled; * = <2 years;° = chronic hepatitis. EACS, European AIDS Clinical Society; OR, odds ratio; CI, confidence interval; HCC, hepatocellular carcinoma.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us